Abstract
We describe a case of a patient with cisplatin-induced hypomagnesemia who suffered brief asystole during an episode of gastroenteritis. Structural heart disease was excluded. The patient achieved complete clinical recovery after short-term administration of intravenous magnesium supplementation. Cisplatin should be considered a cause of hypomagnesemic-related cardiac dysrhythmia. Magnesium deficit may increase myocardial electrical instability and thus, the risk of life-threatening arrhythmias and sudden death. Long-term serum electrolyte measurement and appropriate replacement of magnesium are recommended.
(c) 2006 Wiley-Liss, Inc.
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Bleomycin / administration & dosage
-
Bleomycin / adverse effects
-
Bone Neoplasms / complications
-
Bone Neoplasms / therapy
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects*
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
Dactinomycin / administration & dosage
-
Dactinomycin / adverse effects
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Female
-
Gastroenteritis / drug therapy
-
Gastroenteritis / etiology
-
Heart Arrest / chemically induced*
-
Heart Arrest / drug therapy
-
Humans
-
Magnesium* / administration & dosage
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Osteosarcoma / complications
-
Osteosarcoma / therapy
-
Water-Electrolyte Imbalance / chemically induced*
-
Water-Electrolyte Imbalance / drug therapy
Substances
-
Bleomycin
-
Dactinomycin
-
Doxorubicin
-
Cyclophosphamide
-
Magnesium
-
Cisplatin
-
Methotrexate